IL17A and rheumatoid arthritis: In addition, CD3+ T cells and CD3+ CD8+ T cells were decreased after treatment, whereas there was no significant change in Th17 cells, as well as IL17A secretion in CD4+ T cells, which was not consistent with the findings in RA patients,24 indicating a different pathogenesis between IgG4‐RD and RA.